Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IL4RA | P24394 | Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)] | Cancer-related genesCD markersFDA approved drug targets | 1 | AsthmaAtopic eczemaIdiopathic interstitial pneumonitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| IL7RA | P16871 | Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127) | Cancer-related genesCD markersDisease related genes | 1 | SCIDAtopic eczemaDiabetes mellitus | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| ILDR2 | Q71H61 | Immunoglobulin-like domain-containing receptor 2 (Angulin-3) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| IMPG1 | Q17R60 | Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa) (IPM-150) (Sialoprotein associated with cones and rods) | Disease related genesHuman disease related genesPredicted intracellular proteins | Retinitis pigmentosa | Other mediation | 1 | 0.53 | |||
| ITA3 | P26006 | Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain] | Cancer-related genesCD markersDisease related genes | 1 | Epidermolysis bullosa | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| ITA4 | P13612 | Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d) | 1 | AsthmaCerebral ischaemic strokeCrohn disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | |||
| ITA6 | P23229 | Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)] | Cancer-related genesCD markersDisease related genes | 1 | Epidermolysis bullosa | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| ITA7 | Q13683 | Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form] | Disease related genesHuman disease related genesPotential drug targets | 1 | Congenital muscular dystrophy | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| ITAM | P11215 | Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b) | Cancer-related genesCD markersDisease related genes | 1 | Systemic lupus erythematosusPancreatic cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| ITAV | P06756 | Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain] | Cancer-related genesCD markersFDA approved drug targets | 1 | Colorectal cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 |